Rationale and Design of a Multicentre, Double-Blind, Prospective, Randomized, European and Canadian Study: Evaluating Patient Outcomes and Costs of Managing Adults with Post-Stroke Focal Spasticity

Author： Borg Jörgen   Ward Anthony B.   Wissel Jörg   Kulkarni Jai   Sakel Mohamed   Ertzgaard Per   Åkerlund Per   Reuter Iris   Herrmann Christoph   Satkunam Lalith   Wein Theodore   Girod Isabelle   Wright Nicola  

Publisher： Medical Journals Limited

ISSN： 1650-1977

Source： Journal of Rehabilitation Medicine, Vol.43, Iss.1, 2011-01, pp. : 15-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 7, 2015-07 ,pp. : 735-742

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 37, Iss. 1, 2018-01 ,pp. : 394-406

John Wiley & Sons Inc

Access to resources Recommend Favorite

The efficacy of electrical stimulation in reducing the post-stroke spasticity: a randomized controlled study

By Sahin Nilay   Ugurlu Hatice   Albayrak Ilknur  

Disability and Rehabilitation, Vol. 34, Iss. 2, 2012-01 ,pp. : 151-156

Informa Healthcare

Access to resources Recommend Favorite

Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 12, 2015-12 ,pp. : 2405-2410

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prospective randomized double‐blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO‐AB 31/05)

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 429-436

John Wiley & Sons Inc

Access to resources Recommend Favorite